Generate a tailored SOP for Dr. Xingqi Chen. Improve your application with a focused, well-structured draft.
Xingqi Chen is an Associate Professor at Uppsala University in the Department of Immunology, Genetics, and Pathology. He is a Wallenberg Academy Fellow in Medicine, appointed in 2023, and has been involved in multiple academic roles since 2019 including tenure track Assistant Professor. He completed his postdoctoral research in Dr. Howard Chang's group at Stanford University from 2015 to 2018. Chen's academic journey began with a PhD in medical science from the Karolinska Institute, Sweden, from 2009 to 2014. His research focuses on applying recent advances in single-cell technologies, such as single-cell ATAC-seq and single-cell RNA-seq, to explore cellular heterogeneity and the intricate regulatory mechanisms governing cell fate decisions in the context of human disease. Chen aims to uncover epigenetic mechanisms that regulate cellular identity and differentiate malignancy from normalcy in human cells, contributing to the development of diagnostic tools and therapeutic strategies for cancer. His long-term research goal includes identifying actionable molecular targets for precision cancer therapy.
Stanford University • Stanford, CA
Conducted research in Dr. Howard Chang’s group on epigenetic mechanisms and single-cell technologies.
Uppsala University • Uppsala, Sweden
Engaged in research and teaching in the Department of Immunology, Genetics, and Pathology.
Uppsala University • Uppsala, Sweden
Promoted to Associate Professor, with responsibilities in education and research.
General Master's requirements applying across Science, Technology, and Humanities departments.